The prevalence of CD44+/CD24-/low cells within breast tumors, however, has not been significantly associated with clinical characteristics – although tumors with a higher fraction of CD44+/CD24- cells were more commonly found in patients diagnosed with distant metastases [6]. Here, CD24 is linked to breast neoplasm.